Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma

Tissue Antigens

Volumn 70, Issue 6, 2007, Pages 464-469

  Wei, Y S ^a   Xu, Q Q ^a   Wang, C F ^a   Pan, Y ^a   Liang, F ^a   Long, X K ^a  

^a YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

Author keywords

ESCC; Genetic alteration; Polymorphism; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; TUMOR GROWTH;

CARCINOMA, SQUAMOUS CELL; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA1; VARIATION (GENETICS);

EID: 35948999758     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.00935.x     Document Type: Article

References (43)

1. Blot WJ. Esophageal cancer trends and risk factors. Semin Oncol 1994 : 21 : 403 10.
2. Van Rensburg SJ. Epidemiologic and dietary evidence for a specific nutritional predisposition to esophageal cancer. J Natl Cancer Inst 1981 : 67 : 243 51.
3. Gustavsson P, Evanoff B, Hogstedt C. Increased risk of esophageal cancer among workers exposed to combustion products. Arch Environ Health 1993 : 48 : 243 5.
4. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000 : 342 : 1350 8.
5. Rich J, Borton A, Wang X. Transforming growth factor-beta signaling in cancer. Microsc Res Tech 2001 : 52 : 363 73.
6. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer 2003 : 3 : 807 21.
7. Kang HG, Chae MH, Park JM et al. Polymorphisms in TGF-beta1 gene and the risk of lung cancer. Lung Cancer 2006 : 52 : 1 7.
8. Chung SJ, Kim JS, Jung HC, Song IS. Transforming growth factor-beta1 -509T reduces risk of colorectal cancer, but not adenoma in Koreans. Cancer Sci 2007 : 98 : 401 4.
9. Shin A, Shu XO, Cai Q, Gao YT, Zheng W. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages. Cancer Epidemiol Biomarkers Prev 2005 : 14 : 1567 70.
10. John SW, Weitzner G, Rozen R, Scriver CR. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res 1991 : 19 : 408.
11. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005 : 15 : 97 8.
12. Stephens M, Smith MJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001 : 68 : 978 89.
13. Kondoh K, Usui Y, Ohtani Y, Inase N, Miyake S, Yoshizawa Y. Pro-inflammatory and anti-inflammatory cytokine gene polymorphisms in hypersensitivity pneumonitis. J Med Dent Sci 2006 : 53 : 75 83.
14. Oliver J, Agundez JA, Morales S et al. Polymorphisms in the transforming growth factor-beta gene (TGF-beta) and the risk of advanced alcoholic liver disease. Liver Int 2005 : 25 : 935 9.
15. Buckova D, Izakovicova Holla L, Benes P, Znojil V, Vacha J. TGF-beta1 gene polymorphisms. Allergy 2001 : 56 : 1236 7.
16. Syrris P, Carter ND, Metcalfe JC et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci 1998 : 95 : 659 67.
17. Pulleyn LJ, Newton R, Adcock IM, Barnes PJ. TGF beta1 allele association with asthma severity. Hum Genet 2001 : 109 : 623 7.
18. Piek E, Heldin CH, Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 1999 : 13 : 2105 24.
19. Elliott RL, Blobe GC. Role of transforming growth factor beta in human cancer. J Clin Oncol 2005 : 23 : 2078 93.
20. Mishra L, Derynck R, Mishra B. Transforming growth factor-beta signaling in stem cells and cancer. Science 2005 : 310 : 68 71.
21. Roberts AB, Sporn MB. Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol Reprod Dev 1992 : 32 : 91 8.
22. Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science 2002 : 296 : 1646 7.
23. Tsushima H, Ito N, Tamura S et al. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer. Clin Cancer Res 2001 : 7 : 1258 62.
24. Shariat SF, Kattan MW, Traxel E et al. Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression. Clin Cancer Res 2004 : 10 : 1992 9.
25. Domagala-Kulawik J, Hoser G, Safianowska A, Grubek-Jaworska H, Chazan R. Elevated TGF-beta1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer. Arch Immunol Ther Exp 2006 : 54 : 143 7.
26. Wright JA, Turley EA, Greenberg AH. Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy. Crit Rev Oncog 1993 : 4 : 473 92.
27. Wojtowicz-Praga S. Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J Immunother 1997 : 20 : 165 77.
28. Mocellin S, Wang E, Marincola FM. Cytokines and immune response in the tumor microenvironment. J Immunother 2001 : 24 : 392 400.
29. Grainger DJ, Heathcote K, Chiano M et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999 : 8 : 93 7.
30. Luedecking EK, DeKosky ST, Mehdi H, Ganguli M, Kamboh MI. Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease. Hum Genet 2000 : 106 : 565 9.
31. Dunning AM, Ellis PD, McBride S et al. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003 : 63 : 2610 5.
32. Buck MB, Knabbe C. TGF-beta signaling in breast cancer. Ann N Y Acad Sci 2006 : 1089 : 119 26.
33. Anumanthan G, Halder SK, Osada H et al. Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells. Br J Cancer 2005 : 93 : 1157 67.
34. Narayan S, Thangasamy T, Balusu R. Transforming growth factor-beta receptor signaling in cancer. Front Biosci 2005 : 10 : 1135 45.
35. Woszczyk D, Gola J, Jurzak M, Mazurek U, Mykala-Ciesla J, Wilczok T. Expression of TGF beta1 genes and their receptor types I, II, and III in low- and high-grade malignancy non-Hodgkin's lymphomas. Med Sci Monit 2004 : 10 : CR33 7.
36. Miyajima A, Asano T, Seta K, Asano T, Kakoi N, Hayakawa M. Loss of expression of transforming growth factor-beta receptor as a prognostic factor in patients with renal cell carcinoma. Urology 2003 : 61 : 1072 7.
37. Gonzalez-Zuloeta Ladd AM, Arias-Vasquez A, Siemes C et al. Transforming-growth factor beta1 Leu10Pro polymorphism and breast cancer morbidity. Eur J Cancer 2007 : 43 : 371 4.
38. Lee KM, Park SK, Hamajima N et al. Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk. Breast Cancer Res Treat 2005 : 90 : 149 55.
39. Hishida A, Iwata H, Hamajima N et al. Transforming growth factor β1 T29C polymorphism and breast cancer risk in Japanese women. Breast Cancer 2003 : 10 : 63 9.
40. Kim YJ, Lee HS, Im JP et al. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 2003 : 35 : 196 202.
41. Krippl P, Langsenlehner U, Renner W et al. The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk. Cancer Lett 2003 : 201 : 181 4.
42. Jin Q, Hemminki K, Grzybowska E et al. Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers. Int J Cancer 2004 : 112 : 94 9.
43. Ewart-Toland A, Chan JM, Yuan J, Balmain A, Ma J. A gain of function TGF-β1 polymorphism may be associated with late stage prostate cancer. Cancer Epidemiol Biomarkers Prev 2004 : 13 : 759 64.